Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
679665
Reference Type
Journal Article
Subtype
Review
Title
Influence of etomoxir on the expression of several genes in liver, testis and heart
Author(s)
Hegardt, FG; Serra, D; Asins, G
Year
1995
Is Peer Reviewed?
Yes
Journal
General Pharmacology
ISSN:
0306-3623
EISSN:
1879-0011
Volume
26
Issue
5
Page Numbers
897-904
Language
English
PMID
7557264
DOI
10.1016/0306-3623(94)00281-Q
Web of Science Id
WOS:A1995RE70900003
URL
http://www.sciencedirect.com/science/article/pii/030636239400281Q
Exit
Abstract
1. The effect of ethyl-2-[6-(4-chlorophenoxy)hexyl) oxirane-2-carboxylate (etomoxir) and its oxirane analogues on the expression of several genes from liver and testis as well as the beneficial effect of etomoxir on heart performance and myosin isozyme expression is reviewed. 2. In liver, the effect of etomoxir, alone or in combination with fat or di-(2-ethylhexyl)phthalate (DEHP) on the expression of several genes related to lipid metabolism has been studied. The simultaneous addition of etomoxir and a fat diet produces an increase in the expression of carnitine palmitoyl transferase (CPT) I, cytochrome P-450 4A1 omega-hydroxylase and fatty acid binding protein (L-FABP). The mRNA levels of other genes such as CPT II, 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase, and fatty acid synthase (FAS) are increased by etomoxir alone. Neither cytosolic nor mitochondrial HMG-CoA synthase have any significant effect on the mRNA levels induced by etomoxir. A probably frequent mechanism for the action of etomoxir may involve the overload of non-metabolized fatty acids produced after the inhibition of CPT I by the oxirane compounds. There is some speculation as to whether the peroxisome proliferator activated receptor (PPAR) increases its participation in the expression, under the action of etomoxir. 3. In testis, the changes in several genes related to cholesterogenesis, ketogenesis, fatty acid synthesis and transport of fatty acids into mitochondria have also been reviewed. Etomoxir in testis does not appear to produce any effect either alone or in combination with DEHP or a fat diet.(ABSTRACT TRUNCATED AT 250 WORDS)
Keywords
Animals; Carnitine; Diet; drug effects; enzymology; Epoxy Compounds; Fatty Acids; Gene Expression; Genes; Heart; Humans; Hypoglycemic Agents; Lipid Metabolism; Liver; Male; metabolism; Mitochondria; Myocardium; pharmacology; Spain; Testis
Tags
•
Phthalates – Targeted Search for Epidemiological Studies
Source – all searches
Pubmed
Excluded
Source – no date limit through June 2013 (Private)
Pubmed
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity